Sjögren's Syndrome: Symptoms, Diagnosis, and Treatment

Sjögren's syndrome is a chronic autoimmune disease in which the immune system mistakenly attacks the body's own exocrine glands — primarily the tear and salivary glands — leading to their gradual damage and reduced tear and saliva production. As a clinical review published in the New England Journal of Medicine emphasizes, patients with primary Sjögren's syndrome most often report dry eyes and dry mouth, chronic fatigue, and joint and muscle pain, and the disease carries an elevated risk of developing B-cell lymphoma.

Dry eyes and dry mouth are easily dismissed — treated as an inconvenience related to age, air conditioning, or fatigue rather than a symptom of an autoimmune disease requiring workup. Yet in some patients, Sjögren's syndrome involves far more than just the exocrine glands — it can affect the joints, lungs, kidneys, nervous system, and blood vessels, making it a genuinely systemic disease rather than merely 'dry eye disease.'

Sjögren's syndrome occurs in two main forms. Primary Sjögren's syndrome develops on its own, without another coexisting autoimmune connective tissue disease. Secondary Sjögren's syndrome occurs alongside another diagnosed autoimmune disease — most often rheumatoid arthritis, systemic lupus erythematosus, or systemic sclerosis — and its symptoms overlap with the underlying condition, which sometimes makes it hard to tell which symptoms come from which disease.

The disease affects women far more often than men, and the typical age at diagnosis falls between the fourth and sixth decades of life, though it can occur at any age, including — less commonly — in children. The disease mechanism involves infiltration of the exocrine glands by lymphocytes — immune cells that normally fight infection but, in Sjögren's syndrome, mistakenly attack healthy glandular tissue, gradually damaging its ability to produce secretions.

The practical significance of these criteria is substantial: a diagnosis of Sjögren's syndrome isn't based solely on a subjective sense of dryness, but requires objective confirmation — whether serological (antibodies), histological (biopsy), or functional (an objective measurement of tear and saliva production). This distinguishes Sjögren's syndrome from the far more common isolated dry eye or dry mouth stemming from other causes, such as age, medications, or environmental conditions, where these additional tests remain normal.

Chronic dry mouth has consequences that go beyond mere discomfort — saliva plays an important protective role, neutralizing acids and limiting the growth of cavity-causing bacteria. Patients with Sjögren's syndrome experience significantly more accelerated, extensive tooth decay and oral fungal infections, which makes regular dental care an integral part of treatment rather than a side concern.

In a substantial share of patients, Sjögren's syndrome involves symptoms beyond dry eyes and mouth. The most common are chronic, often debilitating fatigue and joint and muscle pain resembling symptoms of other rheumatologic diseases. Less often, but clinically significantly, the disease can involve the lungs (interstitial lung disease), kidneys (interstitial nephritis), the peripheral nervous system (neuropathy), and blood vessels (vasculitis, purpura).

The cornerstone of managing Sjögren's syndrome remains symptomatic treatment, aimed at relieving dryness and preventing its complications. For the eyes, artificial tears and lubricating preparations of varying viscosity are used, and in more severe cases — topical immunomodulatory drugs such as cyclosporine A eye drops, whose efficacy and safety were confirmed in randomized clinical trials involving more than a thousand patients with dry eye disease.

For dry mouth, saliva-stimulating drugs — pilocarpine and cevimeline — are used, whose effectiveness in improving both subjective dryness and objectively measured salivary flow has been confirmed in several randomized clinical trials. These drugs work by stimulating muscarinic receptors in the remaining, still-functioning glandular tissue — which is why their effectiveness can be limited in patients with very advanced, long-standing gland damage.

In patients with significant involvement of internal organs (lungs, kidneys, nervous system) or pronounced joint symptoms, a rheumatologist may decide to use immunosuppressive or immunomodulatory drugs, similar to those used in other systemic connective tissue diseases — this decision always requires an individual assessment of benefits and risks, since these drugs carry significant potential side effects.

Sjögren's syndrome is a disease that often goes undiagnosed for years, because its most characteristic symptoms — dry eyes and mouth — are easy to rationalize as trivial, attributable to age, stress, or environmental conditions. Yet objective diagnostic criteria exist and can distinguish genuine Sjögren's syndrome from ordinary, isolated dryness — and early diagnosis matters, both for symptomatic treatment and for monitoring rarer but more serious complications.

If chronic dry eyes or dry mouth don't improve despite simple over-the-counter measures, it's worth treating that as a signal to talk to a doctor rather than something to simply learn to live with — especially if accompanied by other unexplained symptoms, like chronic fatigue or joint pain.